Improved waiting-list outcomes in argentina after the adoption of a model for end-stage liver disease-based liver allocation policy

Liver Transplantation

Volumn 19, Issue 7, 2013, Pages 711-720

  Cejas, Nora Gabriela ^a,b   Villamil, Federico G ^a,c   Lendoire, Javier C ^a,b   Tagliafichi, Viviana ^d   Lopez, Arturo ^d   Krogh, Daniela Hansen ^d   Soratti, Carlos A ^d   Bisigniano, Liliana ^d  

^a Argentina Society of Pediatrics   (Argentina)

^b HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^c HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^d Instituto Nacional Central Único Coordinador de Ablación e Implante   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARGENTINA; ARTICLE; DATA BASE; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ARGENTINA; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RESOURCE ALLOCATION; RISK; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS; YOUNG ADULT;

EID: 84879509198     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23665     Document Type: Article

References (23)

1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
2. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R,; for United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7-15.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
4. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580.
5. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026.
6. U.S. Department of Health and Human Services. Technical Notes and Analytic Methods, 2009. Deaths and death rates on the waiting list. http://optn.transplant.hrsa.gov/ar2009/Tech-Notes-AR-CD.htm#6. Accessed April 2013.
7. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
8. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, Mazariegos GV,. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9 (pt 2): 907-931.
9. Freeman RB Jr, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM,. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008; 8 (pt 2): 958-976.
10. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG,. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-343.
11. Cholongitas E, Germani G, Burroughs AK,. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol 2010; 7: 659-668.
12. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA,. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32-39.
13. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-1660.
14. McCormack L, Gadano A, Lendoire J, Imventarza O, Andriani O, Gil O, et al. Model for End-Stage Liver Disease-based allocation system for liver transplantation in Argentina: does it work outside the United States? HPB (Oxford) 2010; 12: 456-464.
15. Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, et al. Multicentric evaluation of Model for End-Stage Liver Disease-based allocation and survival after liver transplantation in Germany-limitations of the 'sickest first'-concept. Transpl Int 2011; 24: 91-99.
16. Freeman RB, Harper A, Edwards EB,. Excellent liver transplant survival rates under the MELD/PELD system. Transplant Proc 2005; 37: 585-588.
17. Yoo HY, Thuluvath PJ,. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 2005; 25: 536-541.
18. Ahmad J, Downey KK, Akoad M, Cacciarelli TV,. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007; 13: 1564-1569.
19. Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12: 440-447.
20. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM,. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 2005; 21: 169-177.
21. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA,. The Model for End-Stage Liver Disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl 2011; 17: 674-684.
22. Massie AB, Caffo B, Gentry SE, Hall EC, Axelrod DA, Lentine KL, et al. MELD exceptions and rates of waiting list outcomes. Am J Transplant 2011; 11: 2362-2371.
23. Wiesner RH, Freeman RB, Mulligan DC,. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127 (suppl 1): S261-S267.